世界の医療産業における3Dプリンティング市場動向・研究開発・売上予測

◆英語タイトル:3D Printing for Healthcare, Trends, R&D and Revenue Forecasts 2016-2026 : Explore Dental Products, Medical Implants, Pharmaceuticals, Bio-printing and Other Uses for Additive Manufacturing
◆商品コード:VGAIN6022515
◆発行会社(調査会社):visiongain
◆発行日:2016年2月
◆ページ数:245
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)GBP1,999 ⇒換算¥319,840見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥479,840見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥799,840見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongain社の日本における正規販売代理店です。visiongain社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、世界の医療産業における3Dプリンティング市場について調査・分析し、以下の構成でお届けいたします。

・レポートの概要
・イントロダクション
・世界の医療産業における3Dプリンティング市場
 (市場規模予測、市場動向、市場の成長要因・阻害要因など)
・世界の医療産業における3Dプリンティング市場:地域別市場分析、市場規模予測
・世界の医療産業における3Dプリンティング市場:研究開発動向
・市場環境分析
・専門家の見解
・主要企業分析
・結論
【レポートの概要】

Three dimensional printing for medicine – your new guide to trends, opportunities and sales potentials
What is the future of fabricating objects from digital models with 3D printers? Visiongain’s new report gives you that data and analysis, letting you explore developments, technology and revenue predictions for uses in healthcare industries.

Our investigation forecasts those revenues to 2026 at overall world market, submarket and national level. Avoid falling behind in knowledge, missing opportunities or losing influence. Instead see what the future holds for additive manufacturing and find the potential gains.

Advances in 3D printing for medicine – find where that printer technology heads
With our updated study you explore the commercial prospects of those computer controlled industrial robots. See outlooks for medical devices, tissues, drugs and other applications.

That way you find potentials for those production tools for creating shapes and patterns as multiform designs. See how those advances can benefit medicine.

Those technologies hold crucial opportunities. So read on to explore that industry and see what its future market could be worth.

Forecasts to 2026 and other information to help you stay ahead in knowledge
Besides revenue forecasting to 2026, our new work shows you recent results, sales growth rates and market shares. You also explore R&D and leading companies. Our study gives 56 tables, 58 charts and seven interviews with other authorities.

Information to help your work and save time, benefiting your influence
Is finding data on novel prototyping and production systems for healthcare proving a challenge? Now make your work easier, also saving time. Discover what the future holds for that emerging technology you cannot afford to ignore.

That way you help yourself stay ahead in knowledge, benefiting your analyses, decisions, authority and reputation for insight.

Forecasting of that world market and its main segments – what is likely to happen?
What are the secrets of 3D printing’s progress? What is the potential of that chemistry, engineering and biotechnology for healthcare? Discover in our report overall world revenue to 2026 for those synthetic processes for medical applications.

Also find individual revenue predictions to 2026 for six submarkets at world level:
• Products – with sub-forecasts for dental products, medical implants, bio-printed tissue and other applications
• Technology – processes for supporting those developments.

Which operations and processes will generate most money from 2016? With our investigation you assess outlooks for revenue growth, seeing where you can gain.

Our analysis helps you identify potential in that synthesis for medicine, producing complex geometries and surfaces. Explore the best revenue-generating applications.

Also see how that emerging industry gives opportunities from 2016 in developed and developing countries.

National markets – where will highest revenues and fastest business expansion occur?
Needs for medical devices, diagnostics and pharmaceuticals worldwide expand use of manufacturing technologies using 3D print methods. In our investigation you examine the scope of three-dimensional printing.

Our analysis shows you individual revenue forecasts to 2026 for 11 countries:
• United States (US)
• Japan
• Germany, France, UK, Italy and Spain (EU5 countries)
• Brazil, Russia, India and China (BRIC group).

In our work you find regions with highest revenues, demand and sales potentials for that production. You discover international prospects, appraising needs and demands.

So explore how technology for multidimensional printing can benefit its developers, producers, marketers, sellers and users from 2016. Our work shows you, discussing trends, prospects and issues.

Events and forces for developing, producing, marketing and selling
The report explains forces affecting that industry and market, including these trends:
• Technologies including selective laser sintering (SLS), direct metal laser sintering (DMLS), electron beam melting (EBM), stereolithography (SLA) and selective laser melting (SLM)
• Bio-printed tissues, cells and compounds, including pharmaceuticals
• Medical models, surgical guides and prototypes
• Orthopaedic and cranio-maxillofacial implants and other medical devices.

You also see how these issues affect that industry and its users:
• Regulatory requirements – abridged pathways, innovations and challenges with 3D technologies and materials
• Replicating vascular tissue – a challenge restraining the bio-printing of replacement organs
• Intervertebral discs, bioengineering, skin grafts, implantable cartilage, blood vessels, heart, lung, liver, bone and reconstructive surgery
• Other advances in research and development, including improving biocompatibility and enhancing usefulness of the 3-dimensional constructs.

In our study you explore economic, political, social and technological questions, investigating outlooks for business. Examine what stimulates and restrains that industry and market. You hear what success is possible and see how you can gain.

Companies and overall 2020 market value – how high can 3D shaping revenues go?
What does the future hold? Our report predicts the world market for those multidimensional printer technologies for health will generate $2854 million in 2020, with further multiplication of revenue to 2026. Discover what is possible.

From 2016, healthcare corporations and specialty providers of that chemical and engineering technology can prosper. You discover how, why and when progress can occur. See what is possible.

You assess activities, progress and outlooks of organisations including these:
• Stratasys
• 3D Systems
• EOS
• Tissue Regeneration Systems
• Oxford Performance Materials
• Tronrud Engineering
• Arcam AB
• Organovo
• Bio3D Technologies
• Aprecia Pharmaceuticals Company.

In our study you also discover seven interviews with authorities in the field – technology firms and other organisations. That way you find what companies and other innovators say, think and do, helping you stay ahead in knowledge.

【レポートの目次】

1. Report Overview
1.1 Overview of 3D Printing for Healthcare: R&D, Industry and Market 2016-2026
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2. Introduction to the 3D Printing for the Healthcare Industry
2.1 3D Printing
2.1.1 Stereolithography – The First 3D Printing Method
2.1.2 Selective Laser Sintering (SLS), Direct Metal Laser Sintering (DMLS) and Selective Laser Melting (SLM)
2.1.3 Electron Beam Melting (EBM)
2.2 Bio-printing Organic Living Cells
2.2.1 Approaches to Bio-printing
2.2.2 Applications for Bio-printing
2.3 3D Printing Pharmaceuticals
2.4 Classifying Medical Devices
2.4.1 The US Medical Devices Classification System
2.4.2 The EU Medical Device Classification System

3. The 3D Printing Healthcare Global Market 2016-2026
3.1 The Current State of the 3D Printing for Healthcare Market
3.2 3D Printed Products in the Healthcare Industry: Submarket Breakdown
3.2.1 Dental Product Submarket is still the Current Majority Market Share Holder
3.3 Global Forecast for the 3D Printed Market 2016-2026
3.4 Drivers and Restraints for the Global 3D Printed Healthcare Market
3.4.1 Drivers of the Global 3D Printed Healthcare Market
3.4.2 Restraints for the 3D Printed Healthcare Market
3.5 The 3D Printing Market for Healthcare: Technology vs. Products Revenue Forecast
3.5.1 Technology: Revenue Forecast 2016-2026
3.5.2 Drivers and Restraints for the 3D Printed Healthcare Technology Submarket
3.5.3 Products Revenue Forecast 2016-2026
3.5.4 Drivers and Restraints for the 3D Printed Healthcare Products Submarket
3.6 The 3D Printing Market for Healthcare: Product Submarket Revenue Forecasts 2016-2026
3.6.1 Dental Products: Revenue Forecast 2016-2026
3.6.2 Medical Implants: Revenue Forecast 2016-2026
3.6.2.1 Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are Produced Using 3D Printing Technology
3.6.2.2 Drivers and Restraints for the 3D Printed Medical Implants, 2016
3.6.2.3 FDA Approvals for 3D Printed Medical Implants
3.6.3 Bio-printed Tissue: Revenue Forecast 2016-2026
3.6.4 Bio-printed Tissue: Commercial Uses
3.6.4.1 Bio-printed Liver Tissue: Preclinical Drug Testing
3.6.4.2 Bio-printed Skin: Opportunities in Cosmetics and Burn Victims
3.6.4.3 Bio-printed Cartilage: Facial Disfigurements and Knee Replacements
3.6.5 Other Applications: Revenue Forecast 2016-2026
3.6.5.1 3D Printed Surgical Tools: Accurate yet Expensive
3.6.5.2 3D Printed Medical Modelling
3.6.5.3 3D Printed Pharmaceuticals: 2015 Sees the First FDA Approval
3.6.5.4 3D Printing to Help Combat Cancer

4. Leading National Markets for 3D Printing in Healthcare 2016-2026
4.1 Leading National Markets for 3D Printing in Healthcare, 2016
4.2 Leading National Markets for 3D Printing in Healthcare, 2020
4.3 Leading National Markets for 3D Printing in Healthcare, 2026
4.4 The US will be the Dominant Market in 3D Printed Healthcare for the Duration of the Forecast
4.4.1 America Makes: A ‘National Accelerator’ for US 3D Printed Products
4.4.2 FDA Regulatory Requirements: Abridged Pathways Encourage Innovation
4.5 The EU5 Will Account for almost third of the Market in 2016; How Will This Change over the Coming 10 years?
4.5.1 Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period
4.5.2 France Demonstrates Strong Growth but a Deceasing Market Share
4.5.3 The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of those Products
4.5.4 Italian Orthopaedic Manufacturers are Prominent Consumers of AM Technology
4.5.5 Spain has the Smallest 3D Printing for Healthcare Market in the EU5
4.6 Japan Will be Overtaken as the Second Largest Market by China in 2017
4.7 The BRIC Nations Show Strong Growth from 2020-2026
4.7.1 China: Domestic Innovation is Keeping Pace with the West
4.7.1.1 Chinese Market Restraints to 3D Printing for Healthcare
4.8 Russian Recession Creates Challenges from 2015-2019
4.9 Brazil’s Rapidly Growing Dental Market Presents Opportunities for 3D Printing
4.10 The Indian Market is in its Infancy
4.11 The Rest of The World Market is Fast Growing

5. Market Leading Organisations
5.1 Market Leaders in Technology: Hardware and Software
5.1.1 Stratasys: Activities and Outlooks
5.1.1.1 Growth Strategies for Stratasys
5.1.2 3D Systems: Achievements and Activities
5.1.3 EOS: A Market Leader in the Technology Submarket
5.1.4 Autodesk Within: Autodesk Acquires Within Technologies
5.1.5 Renishaw: UK-based 3D Printer Manufacturer
5.2 Market Leaders in the Medical Implant/Dental Product Submarkets
5.2.1 Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal Reconstruction Implants
5.2.2 Oxford Performance Materials: Innovators with FDA Approvals to Match
5.2.3 C&A Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling Fields
5.2.4 Tronrud Engineering: A Provider
5.2.5 Aortica: Abdominal Aortic Aneurysm Specialists
5.2.6 Proto Labs Acquires Alphaform AG
5.2.7 3T RPD Ltd: A Large Contributor to the U.K. National Market
5.2.8 Arcam AB: Acquisitions Give Coverage of the Entire Production Line
5.2.9 Xilloc Medical: Patient-Specific Implants from Design to Production.
5.2.10 Fripp Design and Research: Commercial Products in the Pipeline
5.2.11 Materialise NV: A Global Software and Printing Services Provider
5.2.12 4WEB Medical: Strong Growth with More in the Pipeline
5.2.13 Replica 3dm: Offering Medical Models for the NHS
5.2.14 Zdravprint: 3D Printed Casts
5.3 Leading Organisations in the 3D Bio-printing Submarket
5.3.1 Organovo: the First Bio-printed Tissue on the Market
5.3.1.1 Organovo exVive 3D Bio-printed Liver Tissue
5.3.1.2 Organovo: 3D Printed Kidney Tissue in the Pipeline
5.3.2 RegenHU: Creating 3D Bio-printers and Bioinks
5.3.3 Bio 3D Technologies: The World’s First Modular Bio-printer
5.3.4 Osteopore International: Two FDA Approved Products
5.3.5 EnvisionTEC: 3D Printing and Bio-printing Solutions
5.3.6 Dentca
5.3.7 Rainbow Biosciences: Bio-printing based on Magnetic Nanoparticles
5.3.8 Wake Forest Institute for Regenerative Medicine: 3D Bio-printing Research
5.3.8.1 Bio-printed Tissue for Drug Development
5.4 When will Bio-printing be Commercially Available?
5.5 3D Printed Pharmaceuticals: Was 2015 a Watershed Year for the Pharmaceutical Industry?
5.5.1 Aprecia Pharmaceuticals Receives FDA Approval for Spritam, the First of a Kind
5.5.2 The Cronin Group, University of Glasgow: Research into 3D Printing Pharmaceuticals
5.5.3 FabRx: Changing the Shape of Drugs

6. 3D Printing for the Healthcare Industry: The R&D Pipeline
6.1 The Pipeline for 3D Printed Medical Implants
6.1.1 3D Printed Tracheal Splints
6.1.2 Improving Biocompatibility of 3D Printed Medical Implants
6.1.2.1 Vitamin B2 Can Improve Biocompatibility of 3D Printed Medical Implants
6.1.2.2 Silicone is a Biocompatible Material Which Can be Used to Encase Implants
6.1.3 3D Printing for Spinal Implants
6.1.3.1 3D Printed Titanium Spinal Implants
6.1.3.2 3D Printed Intervertebral Discs Could Look Forward to a Share of a $90bn Market
6.1.3.3 3D Printing to Help Treat Babies With Spina Bifida
6.1.4 Printing a Bionic Eye
6.2 The Pipeline for 3D Printed Bioengineering
6.2.1 3D Printing Human Skin
6.2.2 3D Printing Cartilage: Research Making Commercial Availability Tangible
6.2.3 3D Printing Vascular Tissue is a Complex Challenge Restraining the Bio-printing of Entire Organs
6.2.3.1 Revotek: Creating a Blood Vessel Printer
6.2.3.2 Bio-ink Research at Harvard University
6.2.3.3 3D Printed Thryroid Gland – the First 3D Printed Organ?
6.2.3.4 Sugar and Silicone Casted Blood Vessels
6.2.3.5 The Artivasc 3D Project at the Fraunhofer Institute
6.2.4 3D Printing to Fabricate Artificial Heart Valves
6.2.5 3D Printing of the Nipple Areola Complex Graft for Reconstructive Surgery
6.2.6 3D Printing Stem Cells
6.3 The Pipeline for Other 3D Printed Healthcare Applications
6.3.1 Eyedrivomatic: A 3D Printed Wheelchair
6.3.2 3D Printed Pharmaceuticals: Changing Dose, Shape and API
6.3.2.1 3D Printed Polypill for Cardiovascular Disease
6.3.2.2 3D Printing New Active Pharmaceutical Ingredients
6.3.2.3 Aprecia Have Three Products in their Pipeline
6.3.2.4 Bringing Pharmaceuticals to Lesser Economically Developed Countries
6.3.3 3D Printed Microbots for Healthcare

7. Qualitative Analysis of the 3D Printing Industry for Healthcare, 2016-2026
7.1 Strengths of the 3D Printing for Healthcare Industry
7.1.1 Growth Rates Are High – 3D Printing Holds Great Potential
7.1.2 Demand for Customised Products is Increasing
7.1.3 3D Printed Products Can Improve Health Outcomes and Reduce Costs Incurred on Health Systems
7.1.4 More Efficient Use of Economic Resources in Manufacturing
7.1.5 3D Printing Produces Complex Shapes and Parts
7.1.6 3D Printing Technology is Advancing Rapidly
7.2 Weaknesses of the 3D Printing for Healthcare Industry
7.2.1 3D Printing is Expensive Technology
7.2.2 Traditional Economies of Scale Cannot Yet be Achieved with AM
7.2.3 AM is a New Technology which Requires Fewer Workers and New Expertise
7.2.4 Access to Technology and Expertise is Currently Limited
7.2.5 New Legislation will be Enforced Which Could Slow Advances
7.3 Opportunities for the 3D Printing for Healthcare Market, 2016-2026
7.3.1 Governments are Funding 3D Printing R&D Projects
7.3.2 Increasing Demand for Personalised Medicine Represents a Lucrative Opportunity
7.3.3 New Applications for 3D Printing Technology are Being Developed
7.3.4 Post-Production Finishing Will Require New Expertise
7.4 Threats to the 3D Printing for Healthcare Industry, 2016-2026
7.4.1 Regulatory Guidelines Must be Clarified
7.4.2 A Media Coverage May Lead to An Investment Bubble
7.4.3 High Volume Manufacturing is More Economical Using Traditional Methods
7.4.4 There May be Unknown Side Effects Harmful to Health
7.5 A STEP Analysis of the 3D Printing for Healthcare Market
7.6 Social Influences on the 3D Printing for Healthcare Market
7.7 Technological Influences on Market Trends
7.8 Economic Influences on the Market
7.9 Political Influences on the Market

8. Research Interviews
8.1 Interview with Dr Stephen Hilton, UCL School of Pharmacy, FabRx, 3D Synthesis
8.1.1 On 3D Printing Research at UCL, FabRx and 3D Synthesis
8.1.2 On the Use of Hardware and Software
8.1.3 On Commercial Ambitions for FAbRx
8.1.4 On the Benefits and Barriers to 3D Printing in Healthcare
8.2 Interview with Evan Youngstrom, Venture Counsel, Wilson Sonsini Goodrich & Rosati Professional Corporation
8.2.1 On Intellectual Property Challenges
8.2.2 On the Different Challenges Between Implants and Pharmaceuticals
8.2.3 On the First FDA Approved 3D Printed Drug
8.3 Interview with Peter Leys, Executive Chairman, Materialise N.V
8.3.1 On the Beginning of Materialise N.V.
8.3.2 On the Medical Products and Services Offered by Materialise N.V.
8.3.3 On Materialise’s Most Lucrative Products and Markets in 2015 and Beyond
8.3.4 On Regulatory Challenges Facing 3D Printing in the Healthcare Industry
8.3.5 On the Prospects of Materialise N.V. Over the Forecast Period
8.4 Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo
8.4.1 On the Application for 3D Bio-printing
8.4.2 On the Commercial Prospects of the Technology
8.4.3 On the Potential Factors That Could Inhibit Development
8.4.4 On their Newly Released exVive 3D Liver Human Tissue
8.4.5 On the Future of Organovo and the 3D Bio-printing Industry
8.5 Interview with Jim Fitzsimmons, President and CEO, Tissue Regeneration Systems
8.5.1 On the Background of TRS
8.5.2 On TRS’ Portfolio
8.5.3 On Their Commercialization Strategy
8.5.4 Future
8.6 Interview with Matthew Sherry, Managing Director, Replica 3dm
8.6.1 On the History Behind Replica 3dm
8.6.2 On Their Services and R&D Pipeline
8.6.3 On Replica 3DM’s Growth Plans
8.6.4 On the 3D Printing for Healthcare Industry
8.7 Interview with Lee Cronin, Regius Chair of Chemistry, University of Glasgow
8.7.1 On the Cronin Group’s 3D Printed Technology
8.7.2 On Commercialisation Opportunities for Their Technology

9. Conclusions from Our Study
9.1 The Overall 3D Printing for Healthcare Market can be Broken Down into Technology and Products
9.2 Revenue for 3D Printed Healthcare Product Submarkets 2016-2026
9.3 Leading National Markets for 3D Printing in the Healthcare Industry 2016-2026
9.4 Market Trends for 3D Printing in Healthcare 2016-2026
9.4.1 Centralised Organisations will Foster Growth
9.4.2 Opportunities in Technology Development and Raw Material Production
9.4.3 Increased Demand for Personalised Products is leading to Greater Penetration of Technology
9.4.4 3D Printing is Most Established in the Product Submarket of Dentistry
9.4.5 2015 Was a Landmark Year for the 3D Printed Pharmaceuticals
9.4.6 Bio-printing Will Start to Bring in Commercial Revenue Within the Forecast Period
9.4.7 Concluding Remarks

List of Tables
Table 1.1 Leading National Market Forecasts ($m): AGRs (%), Market Shares (%) and CAGRs (%) for 3D Printing in Healthcare, 2015-2026
Table 2.1 The US Classification of Medical Devices
Table 2.2 The EU Classification of Medical Devices
Table 3.1 Breakdown of the Market by Technology and Products: Revenue ($m) and Market Share (%), 2015
Table 3.2 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%), 2015, 2020 and 2026
Table 3.3 3D Printing for Healthcare: Global Market Forecast ($m), 2016-2026
Table 3.4 3D Printing Technology and Products for Healthcare: Market Share (%) and Market Size ($m), 2020
Table 3.5 3D Printing Technology and Products for Healthcare: Market Share (%) and Market Size ($m), 2026
Table 3.6 3D Printing Technology for Healthcare: Revenue Forecasts ($m), 2016-2026
Table 3.7 3D Printing Products for Healthcare: Revenue Forecast ($m), 2016-2026
Table 3.8 3D Printed Products for Healthcare by Submarket: Revenue ($m) and Market Share (%) Forecasts, 2016-2026
Table 3.9 3D Printing for Healthcare Product Submarket Revenue ($m) and Market Shares (%), 2015
Table 3.10 3D Printing for Healthcare Product Submarket Revenue ($m) and Market Shares (%), 2020
Table 3.11 3D Printing for Healthcare Product Submarket Revenue ($m) and Market Shares (%), 2026
Table 3.12 3D Printed Dental Products: Revenue ($m) and Market Share (%) Forecast, 2016-2026
Table 3.13 3D Printed Medical Implants: Revenue ($m) and Market Share (%) Forecast, 2016-2026
Table 3.14 Bio-printed Tissue: Revenue ($m) and Market Share (%) Forecast, 2016-2026
Table 3.15 Other Applications: Revenue ($m) and Market Share (%) Forecast, 2016-2026
Table 4.1 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Comparisons of Revenue ($m) and Market Share (%), 2016, 2020, 2026
Table 4.2 Leading National Markets ($m) and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2020
Table 4.3 Leading National Markets ($m) and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2026
Table 4.4 Leading National Markets: Revenue Forecasts ($m), AGRs (%), Market Shares (%) and CAGRs (%) for 3D Printing in Healthcare, 2015-2026
Table 4.5 US 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2016-2026
Table 4.6 EU5 National Markets ($m) for 3D Printing for Healthcare Forecast, 2016-2026
Table 4.7 German National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.8 French National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.9 UK National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.10 Italian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.11 Spanish National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.12 Japanese National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.13 Chinese National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.14 Russian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.15 Brazilian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.16 Indian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 4.17 RoW National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
Table 5.1 Market Leading Organisations in the 3D Printing for Healthcare Market, 2016
Table 5.2 Stratasys Acquisition History
Table 5.3 3D Systems Healthcare-Related Acquisition History, 2012-2014
Table 5.4 Medical Implants Designed Using Within Technologies' Software
Table 5.5 Renishaw Overall Revenue ($m) and Revenue from Healthcare ($m), 2011-2016
Table 5.6 Oxford Performance Materials’ Products to Receive FDA 510(K) Clearance
Table 5.7 Raw Materials Supplied by EOS and Used by C&A Tools for 3D Printed Products
Table 5.8 Arcam AB Actual Net Sales and Net Sales of Implants (2010-2014) and Forecasted Net Sales and Net Sales of Implants (2015-16)
Table 5.9 Leading Organisations in 3D Bio-printing, 2016
Table 5.10 EnvisionTEC 3D Printing Systems Available for the Medical and Dental Industries, 2016
Table 5.11 Prominent Organisations in the 3D Printed Pharmaceutical Industry, 2016
Table 6.1 Pipeline Areas and Locations of Research for 3D Printed Medical Implants, 2016
Table 6.2 Pipeline Areas and Locations of Research for 3D Printed Bioengineered Products, 2016
Table 6.3 Wake Forest Institute for Regenerative Medicine Research Areas, 2016
Table 6.4 Pipeline Areas and Locations of Research for Other 3D Printed Healthcare Applications, 2016
Table 7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare, 2016
Table 7.2 Opportunities and Threats for the 3D Printing Industry for Healthcare, 2016-2026
Table 7.3 Platinum Member of America Makes, 2016
Table 7.4 Public Partners of America Makes, 2016
Table 7.5 Technological Improvements on 3D Printing Systems, 2016
Table 7.6 Technological Improvements on 3D Printing Software, 2016
Table 7.7 Technological Improvements on 3D Printing Raw Materials, 2016

List of Figures
Figure 1.1 Breakdown of the 3D Printing for Healthcare Market, 2016
Figure 3.1 Breakdown of the Market by Manufacturing Technology and Products, 2015
Figure 3.2 3D Printed Products for Healthcare by Application Market Share (%), 2015
Figure 3.3 Global Revenue Forecast for the 3D printed Healthcare Market, 2016-2026
Figure 3.4 3D Printing in the Healthcare Industry: Annual Growth Rates, 2016-2026
Figure 3.5 Drivers and Restraints of the 3D Printing for Healthcare Industry, 2016
Figure 3.6 3D Printing Technology and Products for Healthcare: Market Share (%), 2020
Figure 3.7 3D Printing Technology and Products for Healthcare: Market Share (%), 2026
Figure 3.8 Technology Revenue Forecast for the 3D Printed Healthcare Market, 2016-2026
Figure 3.9 Drivers and Restraints for the 3D Printed Healthcare Technology Submarket, 2016
Figure 3.10 Product Revenue ($m) Forecast for the 3D printed Healthcare Market, 2016-2026
Figure 3.11 Product AGR (%) Forecast for the 3D printed Healthcare Market, 2016-2026
Figure 3.12 Drivers and Restraints for the 3D Printed Healthcare Product Submarkets, 2016
Figure 3.13 3D Printed Products for Healthcare by Application: Revenue Forecast ($m), 2016-2026
Figure 3.14 3D Printing for Healthcare Product Submarket Revenue Shares (%), 2015
Figure 3.15 3D Printing for Healthcare Product Submarket Revenue Shares (%), 2020
Figure 3.16 3D Printing for Healthcare Product Submarket Revenue Shares (%), 2026
Figure 3.17 Drivers and Restraints of the 3D Printed Dental Product Submarket, 2016
Figure 3.18 Drivers and Restraints on the 3D Printed Medical Implants Submarket, 2016
Figure 3.19 Drivers and Restraints for 3D Printed Surgical Guides and Medical Modelling Market, 2016
Figure 3.20 Drivers and Restraints for the 3D Printed Pharmaceutical Market, 2016
Figure 4.1 Leading National Markets and Market Shares for 3D Printing Technology and Products for Healthcare, 2016
Figure 4.2 Leading National Markets and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2020
Figure 4.3 Leading National Markets and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2026
Figure 4.4 The US: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.5 The US: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.6 The EU5 3D Printing Market for Healthcare: Market Share by Country (%), 2016
Figure 4.7 Revenue Forecasts ($m) for EU5 3D Printing for Healthcare National Markets, 2016-2026
Figure 4.8 Germany: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.9 Germany: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.10 France: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.11 France: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.12 The UK: 3D Printing Market for Healthcare: Revenue Forecast ($m), 2016-2026
Figure 4.13 The UK: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.14 Italy: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.15 Italy: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.16 Spain: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.17 Spain: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.18 Japan: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.19 Japan: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.20 China: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.21 China: 3D Printing Market for Healthcare: AGR Forecast (%), 2016-2026
Figure 4.22 Russia: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.23 Russia: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.24 Brazil: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.25 Brazil: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.26 India: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.27 India: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 4.28 RoW: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
Figure 4.29 RoW: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
Figure 5.1 Renishaw Healthcare Revenue ($m) 2011-2016.
Figure 5.2 Breakdown of Arcam AB’s Sales by Application, 2014
Figure 5.3 Arcam AB Actual Net Sales and Net Sales of Implants (2010-2014) and Forecasted Net Sales and Net Sales of Implants (2015-16)
Figure 6.1 Recipients and Deaths from Those on the Kidney Transplant Waiting List in The US, 2014
Figure 7.1 STEP Analysis of the 3D Printing for Healthcare Industry, 2016-2026
Figure 9.1 3D Printing for the Healthcare Industry: Revenue Forecast ($m) Broken Down Into Technology and Products, 2016-2026
Figure 9.2 Printed Products for the Healthcare Industry by Submarket: Comparisons of Revenue ($m), 2015, 2020 and 2026
Figure 9.3 Leading National Markets in the 3D Printing Industry for Healthcare: Market Shares in 2016, 2020, 2026

【レポートのキーワード】

3Dプリンティング、医療、歯科、医療インプラント、製薬、バイオプリンティング、製造、ヘルスケア

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界の医療産業における3Dプリンティング市場動向・研究開発・売上予測]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。H&I文字はH&Iグローバルリサーチ株式会社の商標(登録第5783645号)です。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。
※当サイトでは2016年05月29日現在 190,440 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆